Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

David Song | Cardiovascular Disease | Excellence in Research

Dr. DavidSong | Cardiovascular Disease | Excellence in Research

Dr. DavidSong, Icahn School of Medicine at Mount Sinai Elmhurst, United States

Dr. David Song is a dedicated cardiologist with extensive medical training and a passion for education and research. He earned his Doctorate of Osteopathic Medicine from Rowan University and completed his Internal Medicine Residency at Icahn School of Medicine. Dr. Song’s accolades include awards for teaching, research, and professionalism. As an Executive Chief Resident, he demonstrated leadership at ISMMS/Elmhurst. Beyond medicine, Dr. Song is a Black Belt in Korean Kumdo and has a history of community service. His commitment extends to mentoring, tutoring, and various leadership roles. 🩺🏆📚

Publication Profile:

Scopus 

Orcid

Education:

Dr. David Song’s academic journey reflects a profound commitment to medical excellence. Beginning with a Bachelor of Science in Neuroscience from Stony Brook University, where he graduated with honors, Magna Cum Laude, Dr. Song continued to Rowan University for his Doctorate of Osteopathic Medicine. He further honed his skills through an Internal Medicine Residency at Icahn School of Medicine, followed by a Chief Residency. Currently, he is pursuing a Clinical Fellowship in Cardiovascular Disease at New York Presbyterian/Queens. Dr. Song’s educational odyssey embodies a relentless pursuit of knowledge and expertise in cardiovascular health. 🩺

Honors and Awards:

Dr. David Song stands as a beacon of academic excellence, adorned with numerous accolades throughout his educational journey. His achievements include being recognized as Internal Medicine PGY-3 Resident Teacher and Resident of the Year at Icahn School of Medicine. Dr. Song’s dedication to research earned him the First Place Research Poster Award and membership in the prestigious Alpha Omega Alpha Honor Medical Society. Notably, he received the Doximity Most Cited Research and Top Published Research Awards, showcasing his impact in the medical field. Beyond academics, his commitment to community service is exemplified by scholarships, leadership awards, and extensive involvement in medical missions. 🏆👨‍⚕️

Work Experience:

Dr. David Song’s multifaceted career includes serving as the Executive Chief Resident at ISMMS/Elmhurst, showcasing his leadership in medical education. His commitment extends to mentorship through the Central Academic Assistance Program at Central Presbyterian Church, where he imparted knowledge to high school students. Dr. Song’s research expertise shines through his role as a Clinical Research Coordinator at Penn Medicine, where he contributed to therapeutic lipid-lowering drug development. His dedication to education continued as a Peer Tutor at Rowan SOM and Head Instructor at Plainview Summer School. Beyond academia, Dr. Song’s analytical skills were honed as an Analytical Chemist, and he contributed significantly as a Research Assistant at Stony Brook University. 🌐👨‍🏫

Research Focus:

Dr. David Song, a distinguished researcher in cardiovascular medicine, has made significant contributions to the field through a prolific body of work. His research focuses on diverse topics, ranging from the intricacies of mitral regurgitation in heart failure to meta-analyses comparing different percutaneous coronary interventions. Dr. Song collaborates with esteemed colleagues, consistently publishing in reputable journals such as Radiology Case Reports and The American Journal of Cardiology. His dedication to unraveling complex medical scenarios, including the impact of COVID-19 on cardiovascular outcomes, showcases a commitment to advancing medical knowledge. 📊🔬

Publication Top Notes: